CeriBell, Inc. (CBLL) — Stock Valuation & Research

CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope,…

CBLL key statistics

Price$24.72
Market cap$937.75M
SectorHealthcare
IndustryMedical - Devices
ExchangeNASDAQ
52-week range10.85-25.627
Beta0.81

Explore CBLL's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.